Objective: To describe the methods by which remarkable levels of subject retention and adherence were achieved in a 30-month multicenter randomized placebo-controlled trial (RCT) of a disease-modifying osteoarthritis drug (DMOAD).
Methods: Subjects were obese 45-64-year-old women with unilateral knee osteoarthritis. Before randomization, each volunteer completed a 4-week "faintness-of-heart" (FOH) test, during which she was required to demonstrate reliable appointment keeping and > or =80% adherence to the dosing regimen. Subjects who passed the FOH test were randomized to treatment with doxycycline or placebo for 30 months. The double-blind phase entailed 15 bimonthly followup visits; intervisit adherence data were downloaded from the dosing monitor and used to estimate therapeutic coverage and to identify correctable patterns of nonadherence. Subjects received token incentives and a small cash payment at each followup visit. Measures to prevent or treat side effects of doxycycline were dispensed free of charge. Study coordinators monitored safety and reinforced participation through between-visit telephone calls.
Results: Of 463 eligible volunteers, 32 (7%) failed the FOH test and were excluded from the double-blind phase. Among the 431 subjects randomized to treatment groups, 307 (71%) completed the 30-month RCT and 124 discontinued the study drug prematurely. Nearly half of the dropouts returned for their 16- and 30-month radiographs, resulting in loss to followup of 14.8% of randomized subjects. The 2 treatment groups did not differ significantly with respect to rates of discontinuation or retention. Therapeutic coverage over 30 months was very high in both groups.
Conclusion: The rate of discontinuation in this 30-month RCT (29%) was lower than that of any DMOAD trial of > or =2 years duration published to date. The proportion of subjects for whom 30-month radiographs were available (85%) and adherence to the dosing regimen (mean >80%) also were remarkably high.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/art.20831 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
EEG microstate in people with different degrees of fear of heights during virtual high-altitude exposure.
Brain Res Bull
November 2024
Department of Aerospace Medicine, Air Force Medical University, Xi'an, Shaanxi, China. Electronic address:
Article Synopsis
- * Researchers categorized 69 participants into three FoH groups (no-FoH, mild/moderate FoH, and severe FoH) based on their acrophobia questionnaire scores, and used EEG analysis to assess their brain activity.
- * Findings revealed distinct microstate patterns between groups: reduced occurrence and energy in microstates for those with higher FoH, indicating changes in brain activity related to heightened fear, while a novel non-canonical microstate was also identified.
ENaCγ in Urinary Extracellular Vesicles as an Indicator of MR Signaling in Primary Aldosteronism.
Hypertension
December 2024
Division of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Japan (Y.H., E.K.-O., F.O.-H., O.Y., S.S.).
Article Synopsis
- The study investigates the use of urinary extracellular vesicles (uEVs) as noninvasive biomarkers for mineralocorticoid receptor (MR) signaling in patients with primary aldosteronism (PA), a condition linked to hypertension and cardiovascular issues.
- Using advanced protein analysis techniques, researchers identified 1940 proteins in uEVs and found significant increases in cleaved ENaCγ, a protein associated with aldosterone signaling, in PA patients compared to healthy individuals.
- The findings suggest that ENaCγ could serve as a reliable indicator of renal MR signaling, and alterations in its levels may inform targeted treatments for PA.
Hyperandrogenic eumenorrheic NON-PCOS women women with PCOS after the GnRH-agonist stimulation test preceded by suppression of adrenal steroidogenesis with dexamethasone.
J Clin Transl Endocrinol
September 2024
The Experts Group on Inositol in Basic and Clinical Research and on PCOS (EGOI-PCOS), 00161 Rome, Italy.
The subject of polycystic ovary syndrome (PCOS) has been extensively covered in the literature; however, there is a paucity of data regarding eumenorrheic women with hyperandrogenism and/or hyperandrogenemia without ultrasound evidence of PCO morphology (EuHyperA), and even less data on the comparison between PCOS and EuHyperA subjects. It has previously been shown that around half of PCOS women exhibit a hyper-response of serum 17-hydroxy-progesterone (17-OHP) to the stimulation by GnRH-agonists, also indicated as functional ovarian hyperandrogenism (FOH). Often, this stimulation test is preceded by suppression of the adrenal steroidogenesis with oral dexamethasone (Dex).
View Article and Find Full Text PDFRegioselective fluorination of allenes enabled by I(I)/I(III) catalysis.
Nat Commun
July 2024
Institute for Organic Chemistry, University of Münster, Corrensstraße 36, 48149, Münster, Germany.
The prominence and versatility of propargylic fluorides in medicinal chemistry, coupled with the potency of F/H and F/OH bioisosterism, has created a powerful impetus to develop efficient methods to facilitate their construction. Motivated by the well-established conversion of propargylic alcohols to allenes, an operationally simple, organocatalysis-based strategy to process these abundant unsaturated precursors to propargylic fluorides would be highly enabling: this would consolidate the bioisosteric relationship that connects propargylic alcohols and fluorides. Herein, we describe a highly regioselective fluorination of unactivated allenes based on I(I)/I(III) catalysis in the presence of an inexpensive HF source that serves a dual role as both nucleophile and Brønsted acid activator.
View Article and Find Full Text PDFFear of hypoglycemia in parents of children with type 1 diabetes trained for intranasal glucagon use.
J Psychosom Res
September 2024
Department of the Woman, of the Child and of the General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Naples, Italy.
Objective: To investigate fear of hypoglycemia (FoH) in parents of children with type 1 diabetes (T1D) before and after undergoing training to learn intranasal (IN) glucagon administration.
Method: In this pre-test/post-test uncontrolled study 364 caregivers of patients with T1D (6-18 years) completed questionnaires measuring sociodemographic characteristics, diabetes-related factors (e.g.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!